You're likely seeing more discussions about weight, health, and appearance than ever before, especially with new medications gaining popularity. But the way we talk about these topics is creating a surprising tension between two powerful cultural forces.
The debate intensified as GLP-1 drugs like Ozempic and Wegovy became widely adopted for weight loss, bringing questions about their role in health and societal norms to the forefront.
These medications, originally for Type 2 diabetes, gained FDA approval for chronic weight management in 2021 (Wegovy).